Helena Yu

Helena Yu

Memorial Sloan Kettering Cancer Center - Indore / United States
Others
AD Scientific Index ID: 4441166
person_outline Helena Yu's MOST POPULAR ARTICLES
1-) Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung CancersMechanisms of Acquired Resistance to EGFR-TKI …HA Yu, ME Arcila, N Rekhtman, CS Sima, MF Zakowski, W Pao, MG Kris, ...Clinical cancer research 19 (8), 2240-2247, 201322832013
2-) Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 SkippingMET Inhibitors in MET Exon 14 Splice Variant Lung CancerPK Paik, A Drilon, PD Fan, H Yu, N Rekhtman, MS Ginsberg, L Borsu, ...Cancer discovery 5 (8), 842-849, 20155402015
3-) Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapiesEJ Jordan, HR Kim, ME Arcila, D Barron, D Chakravarty, JJ Gao, ...Cancer discovery 7 (6), 596-609, 20175102017
4-) Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non–Small Cell Lung CancerKC Arbour, E Jordan, HR Kim, J Dienstag, HA Yu, F Sanchez-Vega, P Lito, ...Clinical Cancer Research 24 (2), 334-340, 20184232018
5-) EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical OutcomesN Marcoux, SN Gettinger, G O’Kane, KC Arbour, JW Neal, H Husain, ...Journal of Clinical Oncology 37 (4), 278-285, 20193932019